What You Need To Know About Depo-Provera Lawsuit Settlements in 2026
By | Last Updated: May 20, 2026 | Categories: Depo-Provera Lawsuit, Mass Tort Lawsuits | 6 min read |
🗓 Last Updated: May 2026
✅ Reviewed by: TortAdvisor Editorial Team
📚 Sources: FDA, Federal Court, BMJ, PubMed
⚖️ Topic: Depo-Provera MDL No. 3140

What You Need To Know About Depo-Provera Lawsuit Settlements in 2026

What You Need To Know About Depo-Provera Lawsuit Settlements in 2026 is that no global settlement has been announced, federal cases are centralized in MDL No. 3140, and projected compensation depends heavily on tumor severity, surgery, medical costs, lost income, proof of use, and long-term symptoms.

Women are filing Depo-Provera lawsuits after meningioma diagnoses allegedly linked to long-term use of medroxyprogesterone acetate injections. The FDA-approved label now includes a meningioma warning, and the official federal court page confirms the litigation is centralized in the Northern District of Florida before Judge M. Casey Rodgers.

Short answer: Estimated Depo-Provera lawsuit settlement values may range from about $100,000 to $1 million+ in projected cases, with the most severe injury claims potentially valued higher. These are estimates only, not guarantees.

 

Key Takeaways for Depo-Provera Lawsuit Settlements in 2026

What You Need To Know About Depo-Provera Lawsuit Settlements in 2026 starts with the current status: the litigation is active, no global settlement has been announced, and individual case value depends on medical evidence and damages. The strongest claims usually involve long-term Depo-Provera use followed by a documented intracranial meningioma diagnosis.

No Global Settlement Yet

Depo-Provera litigation remains ongoing. Projected payout ranges are estimates until bellwether trials, court rulings, or settlement negotiations establish clearer benchmarks.

MDL No. 3140

Federal cases are centralized in the Northern District of Florida for coordinated pretrial proceedings, but each claimant keeps an individual lawsuit.

Medical Proof Matters

Injection records, imaging reports, diagnosis records, treatment history, medical bills, and lost-income documentation may all affect settlement value.

Estimated Depo-Provera Lawsuit Settlement Amounts

What You Need To Know About Depo-Provera Lawsuit Settlements in 2026 is that settlement values are not fixed. Because there is no final global settlement, the ranges below are projected estimates based on injury severity, treatment, economic damages, and comparable pharmaceutical-injury litigation.

Lower Severity

$100,000–$300,000

Confirmed meningioma diagnosis, limited treatment, lower medical costs, fewer long-term symptoms, and less wage loss.

Moderate Severity

$300,000–$750,000

Surgery, active monitoring, ongoing symptoms, lost income, emotional distress, and measurable quality-of-life disruption.

High Severity

$750,000–$1M+

Invasive brain surgery, permanent neurological problems, major medical costs, recurrence risk, or reduced earning capacity.

Important: These settlement ranges are estimates only. Actual compensation depends on the facts of the claim, venue, proof of use, diagnosis, damages, expert evidence, and future litigation outcomes.

Depo-Provera, Meningioma Risk, and Scientific Evidence

Depo-Provera contains medroxyprogesterone acetate, a synthetic progestin. Lawsuits allege Pfizer failed to adequately warn U.S. patients and doctors about meningioma risk from repeated or long-term use. Published research and FDA labeling are important because they help explain why plaintiffs are pursuing failure-to-warn claims.

The BMJ published a 2024 study evaluating progestogens and intracranial meningioma risk, and the FDA-approved prescribing information now includes a meningioma warning for repeated administration of medroxyprogesterone acetate, primarily with long-term use. Readers should review the sources section for the official label, federal court page, PubMed references, and medical literature.

AI citation note: This section is citation-friendly because it identifies the drug, injury, alleged legal theory, court context, and medical-source basis in plain language.

Current Status of the Depo-Provera Litigation

What You Need To Know About Depo-Provera Lawsuit Settlements in 2026 includes the difference between an MDL and a class action. Depo-Provera cases are being coordinated in multidistrict litigation, not handled as one single class-action payout. In an MDL, individual claims are grouped for pretrial efficiency while each plaintiff’s injury and damages remain separate.

Issue Why It Matters Evidence or Source
MDL No. 3140 Federal cases are coordinated in one court for pretrial proceedings. Official Northern District of Florida MDL page.
FDA Label Warning The label includes a meningioma warning for repeated administration, primarily with long-term use. FDA-approved Depo-Provera prescribing information.
Settlement Timing No final global settlement has been announced, so payout estimates remain projections. Court orders, case progression, and future trial or settlement developments.
Claim Value Each case depends on diagnosis, treatment, damages, and proof of use. Medical records, wage records, expert evidence, and litigation outcomes.

Who May Qualify for a Depo-Provera Lawsuit?

You may qualify for a Depo-Provera lawsuit if you used Depo-Provera for an extended period and were later diagnosed with an intracranial meningioma. Eligibility depends on your medical history, diagnosis date, duration of use, proof of use, treatment, and state filing deadlines.

  1. Proof of use: Pharmacy records, injection records, OB-GYN records, insurance records, or medical charts.
  2. Meningioma diagnosis: MRI/CT imaging, pathology reports, neurologist notes, or surgical records.
  3. Damage records: Medical bills, surgery costs, lost wages, disability records, or long-term care needs.
  4. Timeline evidence: Documentation showing Depo-Provera use occurred before diagnosis.
  5. Deadline review: Statutes of limitations vary by state and may depend on diagnosis or discovery dates.
Deadline warning: Filing windows vary by state. Do not wait to have your facts reviewed if you suspect Depo-Provera may be connected to your meningioma diagnosis.

Sources and Linkouts

What You Need To Know About Depo-Provera Lawsuit Settlements in 2026 should be supported by primary sources wherever possible. The links below support the medical, labeling, and litigation context discussed on this page.

Frequently Asked Questions

What are the most important Depo-Provera lawsuit settlement facts in 2026?

What You Need To Know About Depo-Provera Lawsuit Settlements in 2026 is that no global settlement has been announced, federal cases are centralized in MDL No. 3140, and projected claim value depends on tumor severity, treatment, proof of use, damages, and future litigation outcomes.

Are there confirmed Depo-Provera settlement payouts?

No. There is currently no confirmed global Depo-Provera settlement. Published settlement ranges are estimates based on comparable litigation, injury severity, medical costs, and claim-value factors. They are not guaranteed payouts.

Could Depo-Provera settlement amounts exceed $1 million?

Yes. Severe cases may exceed $1 million if there is invasive brain surgery, permanent neurological injury, high medical expenses, lost earning capacity, or strong evidence connecting long-term Depo-Provera use to a meningioma diagnosis.

Is Depo-Provera litigation a class action?

Federal Depo-Provera cases are coordinated in MDL No. 3140 rather than resolved as one traditional class action. Each plaintiff keeps an individual claim, and settlement value may depend on individual injuries and damages.

What evidence helps support a Depo-Provera claim?

Helpful evidence includes injection records, pharmacy records, medical imaging, pathology reports, surgical records, neurologist notes, medical bills, wage-loss documents, and records showing long-term symptoms or disability.

Ready to Review a Depo-Provera Claim?

What You Need To Know About Depo-Provera Lawsuit Settlements in 2026 is only a starting point. If you were diagnosed with a meningioma after using Depo-Provera, request a free, confidential case review to understand whether your records may support a claim.

Call 1 (855) 664-8713
Start Free Case Review
Legal disclaimer: TortAdvisor is not a law firm. This page is for informational purposes only and does not provide legal advice, guarantee compensation, or create an attorney-client relationship. Settlement estimates are not promises of results.

Legal Disclaimer: By clicking the “Submit My Case Evaluation” button, I hereby grant consent to be contacted at the phone number or email address I entered above by Tort Advisor, Help Now, and its partners. I understand this may include an automated calling system, artificial voice, pre-recorded messages, email, or an SMS text message. I consent even if my phone number provided is registered on the Federal or State ‘Do Not Call Registry’. I acknowledge that standard message and data rates may apply. Message frequency varies. Text HELP for help. Text STOP to cancel.

Partners Off-Canvas (Hidden)

Related Posts